In this retrospective study involving 1,537 melanoma patients, researchers examined clinicopathological characteristics and the course of melanoma to identify prognostic factors, contrasting early and late recurrence (LR), defined as melanoma recurrence 10 years after the first diagnosis, in patients followed at the Department of Dermatology of the University Hospital of Tübingen between February 1976 and June 2015.
Publications
The interplay of sun-damage and genetic risk in Australian multiple and single primary melanoma cases and controls
This study was undertaken to determine if the level of UV damage at the site of melanomas was correlated with genetic polymorphisms.
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
Researchers investigated the efficacy of the tumor microenvironment-derived protein S100A8/A9 as a prognostic marker for melanoma patients, also in the setting of immunotherapy. Using a cDNA library and three independent tissue-microarrays (TMA), they analyzed S100A8/A9 gene and protein expression on melanocytic nevi, primary melanomas and metastases.
Melanoma Journal Articles for November 2019
Please click on the link to see a list of melanoma journal citations that crossed the MRV desk this month.